Page last updated: 2024-11-12

baci-im

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10909430
CHEMBL ID1200558
CHEBI ID35862
SCHEMBL ID20385900
MeSH IDM0454530

Synonyms (66)

Synonym
solu-tracin 50
baciguent
nsc-45737
bacitracin a2a
n-({(4r)-2-[(1s,2s)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazol-4-yl}carbonyl)-l-leucyl-d-alpha-glutamyl-n-[(3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carboxymethyl)-9-(1h-imidazol-4-ylmethyl)
CHEBI:35862 ,
bacitracin f, 1-(n-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-l-leucine)-
22601-59-8
mycitracin
zutracin
topitracin
penitracin
ak-tracin
einecs 245-115-9
baci-jel
bactine triple antibiotic
parentracin
bacitracinum [latin]
bacitracine [french]
bacitek ointment
campho-phenique triple plus pain reliever
hsdb 6418
ai3-50147-x
baci-rx
nsc 45737
mycitracin triple antibiotic first aid ointment maximum strength
einecs 215-786-2
septa
spectrocin plus
baciim
mycitracin plus pain reliever
bacitracina [spanish]
usaf cb-7
topitrasin
baciliquin
DB00626
tropitracin
CHEMBL1200558
bacilliquin
e700
bacitracin(non-injectable)
bacitracinum
nsc-755905
bacitracin, sterile
nsc 755905
unii-58h6rwo52i
58h6rwo52i ,
bacitracin [usp:inn:ban:jan]
bacitracina
bacitracine
unii-dda3rrx0p7
dda3rrx0p7 ,
l-asparagine, n-(((4r)-2-((1s,2s)-1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-l-leucyl-d-.alpha.-glutamyl-l-isoleucyl-l-lysyl-d-ornithyl-l-isoleucyl-d-phenylalanyl-l-histidyl-d-.alpha.-aspartyl-, (10->4)-lactam
CLKOFPXJLQSYAH-ABRJDSQDSA-N
DTXSID00858765 ,
Q424319
gtpl12812
SCHEMBL20385900
85800-09-5
bdbm50458054
baciferm 50
albac 50
bacitracin powder
l-asparagine, n-(((4r)-2-((1s,2s)-1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-l-leucyl-d-alpha-glutamyl-l-isoleucyl-l-lysyl-d-ornithyl-l-isoleucyl-d-phenylalanyl-l-histidyl-d-alpha-aspartyl-, (10->4)-lactam
dtxcid6025355
n-(((4r)-2-((1s,2s)-1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazol-4-yl)carbonyl)-l-leucyl-d-alpha-glutamyl-n-((3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-((2s)-butan-2-yl)-6-(carboxymethyl)-9-(1h-imidazol-4-ylmethyl)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts."( FDA-approved drug labeling for the study of drug-induced liver injury.
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
homodetic cyclic peptideA homodetic cyclic peptide is a cyclic peptide in which the ring consists solely of amino-acid residues in peptide linkages.
polypeptideA peptide containing ten or more amino acid residues.
zwitterionA neutral compound having formal unit electrical charges of opposite sign on non-adjacent atoms. Sometimes referred to as inner salts, dipolar ions (a misnomer).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Epidermal growth factor receptorHomo sapiens (human)IC50 (µMol)5.37700.00000.536910.0000AID625184
Tyrosine-protein kinase LckHomo sapiens (human)IC50 (µMol)1.92300.00021.317310.0000AID625187
Undecaprenyl-diphosphataseEscherichia coli K-12IC50 (µMol)5.60005.60005.60005.6000AID1382485
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (115)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
MAPK cascadeEpidermal growth factor receptorHomo sapiens (human)
ossificationEpidermal growth factor receptorHomo sapiens (human)
embryonic placenta developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein phosphorylationEpidermal growth factor receptorHomo sapiens (human)
hair follicle developmentEpidermal growth factor receptorHomo sapiens (human)
translationEpidermal growth factor receptorHomo sapiens (human)
signal transductionEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
activation of phospholipase C activityEpidermal growth factor receptorHomo sapiens (human)
salivary gland morphogenesisEpidermal growth factor receptorHomo sapiens (human)
midgut developmentEpidermal growth factor receptorHomo sapiens (human)
learning or memoryEpidermal growth factor receptorHomo sapiens (human)
circadian rhythmEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
diterpenoid metabolic processEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
cerebral cortex cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell growthEpidermal growth factor receptorHomo sapiens (human)
lung developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of superoxide anion generationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
response to cobalaminEpidermal growth factor receptorHomo sapiens (human)
response to hydroxyisoflavoneEpidermal growth factor receptorHomo sapiens (human)
cellular response to reactive oxygen speciesEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
ERBB2-EGFR signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of protein catabolic processEpidermal growth factor receptorHomo sapiens (human)
vasodilationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphorylationEpidermal growth factor receptorHomo sapiens (human)
ovulation cycleEpidermal growth factor receptorHomo sapiens (human)
hydrogen peroxide metabolic processEpidermal growth factor receptorHomo sapiens (human)
negative regulation of apoptotic processEpidermal growth factor receptorHomo sapiens (human)
positive regulation of MAP kinase activityEpidermal growth factor receptorHomo sapiens (human)
tongue developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA repairEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA replicationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of bone resorptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of vasoconstrictionEpidermal growth factor receptorHomo sapiens (human)
negative regulation of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEpidermal growth factor receptorHomo sapiens (human)
regulation of JNK cascadeEpidermal growth factor receptorHomo sapiens (human)
symbiont entry into host cellEpidermal growth factor receptorHomo sapiens (human)
protein autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
astrocyte activationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEpidermal growth factor receptorHomo sapiens (human)
digestive tract morphogenesisEpidermal growth factor receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationEpidermal growth factor receptorHomo sapiens (human)
neuron projection morphogenesisEpidermal growth factor receptorHomo sapiens (human)
epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
protein insertion into membraneEpidermal growth factor receptorHomo sapiens (human)
response to calcium ionEpidermal growth factor receptorHomo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicEpidermal growth factor receptorHomo sapiens (human)
positive regulation of glial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
morphogenesis of an epithelial foldEpidermal growth factor receptorHomo sapiens (human)
eyelid development in camera-type eyeEpidermal growth factor receptorHomo sapiens (human)
response to UV-AEpidermal growth factor receptorHomo sapiens (human)
positive regulation of mucus secretionEpidermal growth factor receptorHomo sapiens (human)
regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
cellular response to amino acid stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to mechanical stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to cadmium ionEpidermal growth factor receptorHomo sapiens (human)
cellular response to epidermal growth factor stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to estradiol stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to xenobiotic stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to dexamethasone stimulusEpidermal growth factor receptorHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
liver regenerationEpidermal growth factor receptorHomo sapiens (human)
cell-cell adhesionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein kinase C activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of prolactin secretionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of miRNA transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein localization to plasma membraneEpidermal growth factor receptorHomo sapiens (human)
negative regulation of cardiocyte differentiationEpidermal growth factor receptorHomo sapiens (human)
neurogenesisEpidermal growth factor receptorHomo sapiens (human)
multicellular organism developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of kinase activityEpidermal growth factor receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
protein phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
intracellular zinc ion homeostasisTyrosine-protein kinase LckHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTyrosine-protein kinase LckHomo sapiens (human)
response to xenobiotic stimulusTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
hemopoiesisTyrosine-protein kinase LckHomo sapiens (human)
platelet activationTyrosine-protein kinase LckHomo sapiens (human)
T cell differentiationTyrosine-protein kinase LckHomo sapiens (human)
T cell costimulationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of heterotypic cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
intracellular signal transductionTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine autophosphorylationTyrosine-protein kinase LckHomo sapiens (human)
Fc-gamma receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell activationTyrosine-protein kinase LckHomo sapiens (human)
leukocyte migrationTyrosine-protein kinase LckHomo sapiens (human)
release of sequestered calcium ion into cytosolTyrosine-protein kinase LckHomo sapiens (human)
regulation of lymphocyte activationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of leukocyte cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
innate immune responseTyrosine-protein kinase LckHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
peptidoglycan metabolic processUndecaprenyl-diphosphataseEscherichia coli K-12
response to antibioticUndecaprenyl-diphosphataseEscherichia coli K-12
regulation of cell shapeUndecaprenyl-diphosphataseEscherichia coli K-12
peptidoglycan biosynthetic processUndecaprenyl-diphosphataseEscherichia coli K-12
response to antibioticUndecaprenyl-diphosphataseEscherichia coli K-12
cell wall organizationUndecaprenyl-diphosphataseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (38)

Processvia Protein(s)Taxonomy
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
virus receptor activityEpidermal growth factor receptorHomo sapiens (human)
chromatin bindingEpidermal growth factor receptorHomo sapiens (human)
double-stranded DNA bindingEpidermal growth factor receptorHomo sapiens (human)
MAP kinase kinase kinase activityEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane signaling receptor activityEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
integrin bindingEpidermal growth factor receptorHomo sapiens (human)
protein bindingEpidermal growth factor receptorHomo sapiens (human)
calmodulin bindingEpidermal growth factor receptorHomo sapiens (human)
ATP bindingEpidermal growth factor receptorHomo sapiens (human)
enzyme bindingEpidermal growth factor receptorHomo sapiens (human)
kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein phosphatase bindingEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
ubiquitin protein ligase bindingEpidermal growth factor receptorHomo sapiens (human)
identical protein bindingEpidermal growth factor receptorHomo sapiens (human)
cadherin bindingEpidermal growth factor receptorHomo sapiens (human)
actin filament bindingEpidermal growth factor receptorHomo sapiens (human)
ATPase bindingEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor bindingEpidermal growth factor receptorHomo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase LckHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
protein serine/threonine phosphatase activityTyrosine-protein kinase LckHomo sapiens (human)
protein bindingTyrosine-protein kinase LckHomo sapiens (human)
ATP bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase activator activityTyrosine-protein kinase LckHomo sapiens (human)
protein kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
protein phosphatase bindingTyrosine-protein kinase LckHomo sapiens (human)
SH2 domain bindingTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD4 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD8 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
identical protein bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase bindingTyrosine-protein kinase LckHomo sapiens (human)
phosphatidylinositol 3-kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
ATPase bindingTyrosine-protein kinase LckHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
pyrophosphatase activityUndecaprenyl-diphosphataseEscherichia coli K-12
hydrolase activityUndecaprenyl-diphosphataseEscherichia coli K-12
undecaprenyl-diphosphatase activityUndecaprenyl-diphosphataseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (30)

Processvia Protein(s)Taxonomy
endosomeEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
ruffle membraneEpidermal growth factor receptorHomo sapiens (human)
Golgi membraneEpidermal growth factor receptorHomo sapiens (human)
extracellular spaceEpidermal growth factor receptorHomo sapiens (human)
nucleusEpidermal growth factor receptorHomo sapiens (human)
cytoplasmEpidermal growth factor receptorHomo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
endoplasmic reticulum membraneEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
focal adhesionEpidermal growth factor receptorHomo sapiens (human)
cell surfaceEpidermal growth factor receptorHomo sapiens (human)
endosome membraneEpidermal growth factor receptorHomo sapiens (human)
membraneEpidermal growth factor receptorHomo sapiens (human)
basolateral plasma membraneEpidermal growth factor receptorHomo sapiens (human)
apical plasma membraneEpidermal growth factor receptorHomo sapiens (human)
cell junctionEpidermal growth factor receptorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneEpidermal growth factor receptorHomo sapiens (human)
early endosome membraneEpidermal growth factor receptorHomo sapiens (human)
nuclear membraneEpidermal growth factor receptorHomo sapiens (human)
membrane raftEpidermal growth factor receptorHomo sapiens (human)
perinuclear region of cytoplasmEpidermal growth factor receptorHomo sapiens (human)
multivesicular body, internal vesicle lumenEpidermal growth factor receptorHomo sapiens (human)
intracellular vesicleEpidermal growth factor receptorHomo sapiens (human)
protein-containing complexEpidermal growth factor receptorHomo sapiens (human)
receptor complexEpidermal growth factor receptorHomo sapiens (human)
Shc-EGFR complexEpidermal growth factor receptorHomo sapiens (human)
basal plasma membraneEpidermal growth factor receptorHomo sapiens (human)
pericentriolar materialTyrosine-protein kinase LckHomo sapiens (human)
immunological synapseTyrosine-protein kinase LckHomo sapiens (human)
cytosolTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
membrane raftTyrosine-protein kinase LckHomo sapiens (human)
extracellular exosomeTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneUndecaprenyl-diphosphataseEscherichia coli K-12
membraneUndecaprenyl-diphosphataseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (118)

Assay IDTitleYearJournalArticle
AID1765577Antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID625278FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of no concern for DILI2011Drug discovery today, Aug, Volume: 16, Issue:15-16
FDA-approved drug labeling for the study of drug-induced liver injury.
AID575421Antimicrobial activity against mprF-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID1191517Antibacterial activity against Enterococcus sp. J 14365/08 after 24 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID575424Antimicrobial activity against telA-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method relative to wild type2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID1191516Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID575334Antimicrobial activity against telA-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID548256Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID1191513Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 24 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID432805Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL at 42 degC by population analysis method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Role of a sodium-dependent symporter homologue in the thermosensitivity of beta-lactam antibiotic resistance and cell wall composition in Staphylococcus aureus.
AID555654Antimicrobial activity against copY and cyl deficient Streptococcus pneumoniae VarF mutant by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID577713Antibacterial activity against 10'5 CFU/ml telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a after 16 hrs by by two fold serial dilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
AID1765578Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID564979Antimicrobial activity against Mycobacterium bovis BCG KOP55 harboring inactivated p55 gene by resazurine microtiter assay in presence of 1 mg/liter CCCP2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID1493160Induction of cell envelope stress in Bacillus subtilis isolate 1S34 assessed as increase in liaI promoter activity at 10 ug after 14 to 18 hrs by beta-galactosidase reporter gene assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID376012Antibacterial activity against vancomycin-resistant Enterococcus faecium at 10 ug after 18 hrs by agar diffusion test1999Journal of natural products, Sep, Volume: 62, Issue:9
Antibacterial diterpenoid acids from Azorella compacta.
AID575422Antimicrobial activity against virR-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method relative to wild type2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID564983Antimicrobial activity against Mycobacterium bovis BCG KOP55 harboring pPAZ23 carrying p27-p55 operon by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1382485Inhibition of Escherichia coli UPPP expressed in Escherichia coli C41(DE3) using FPP as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by malachite green assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
AID1765573Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID575418Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method relative to wild type2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID1493161Induction of cell envelope stress in Bacillus subtilis isolate 1S34 assessed as increase in ypuA promoter activity at 10 ug after 14 to 18 hrs by beta-galactosidase reporter gene assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
AID530526Induction of Ppbp2::lacZ gene expression in Staphylococcus aureus SH1000 at 13.4 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID1765575Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID548474Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID555651Antimicrobial activity against Streptococcus pneumoniae R6 by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID575419Antimicrobial activity against Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID558753Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus H14 harboring vraS S329L mutant gene by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID530747Induction of PlytR::lacZ gene expression in Staphylococcus aureus SH1000 at 13.4 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID1493164Induction of translation arrest in Bacillus subtilis isolate 1S34 assessed as increase in bmrC promoter activity at 10 ug after 14 to 18 hrs by beta-galactosidase reporter gene assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
AID558755Antibacterial activity against methicillin-susceptible, tetracycline-resistant and chloramphenicol-resistant Staphylococcus aureus H14-KVR by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID558756Antibacterial activity against hetero-Methicillin-resistant and tetracycline-resistant and rifampicin-resistant Staphylococcus aureus deltaIP-rifR harboring RpoB H481Y mutant gene by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID548254Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID717781Antimicrobial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Contribution to investigation of antimicrobial activity of styrylquinolines.
AID555659Antimicrobial activity against kanamycin-resistant and spr0811-spr0813::aphIII deficient Streptococcus pneumoniae VarG by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID564978Antimicrobial activity against Mycobacterium bovis BCG KOP55 harboring inactivated p55 gene by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID575425Antimicrobial activity against lisK-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method relative to wild type2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID530769Antimicrobial activity against beta-lactamase producing Staphylococcus aureus SH10002008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID1493163Induction of RNA damage in Bacillus subtilis isolate 1S34 assessed as increase in helD promoter activity at 10 ug after 14 to 18 hrs by beta-galactosidase reporter gene assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
AID564974Antimicrobial activity against Mycobacterium bovis BCG by resazurine microtiter assay in presence of 1 mg/liter CCCP2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1765580Antibacterial activity against Acinetobacter baumannii ATCC 19606 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID548475Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID548473Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID548257Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID1493162Induction of DNA damage in Bacillus subtilis isolate 1S34 assessed as increase in yorB promoter activity at 10 ug after 14 to 18 hrs by beta-galactosidase reporter gene assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID548255Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID530756Induction of PsgtB::lacZ gene expression in Staphylococcus aureus SH1000 at 13.4 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID564988Antimicrobial activity against Mycobacterium bovis BCG harboring pPAZ23 carrying p27-p55 operon by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID575416Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e at 10 ug after 16 hrs by disk diffusion assay2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID1191511Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 24 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID717785Antimicrobial activity against Staphylococcus aureus CCM 4516/08 after 24 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Contribution to investigation of antimicrobial activity of styrylquinolines.
AID717782Antimicrobial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 48 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Contribution to investigation of antimicrobial activity of styrylquinolines.
AID1191518Antibacterial activity against Enterococcus sp. J 14365/08 after 48 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID555657Antimicrobial activity against Streptococcus pneumoniae R6 transformed with DNA containing spr0813 C1744T::aphIII mutant gene selected after kanamycin exposure by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID575337Antimicrobial activity against virR-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1191521Cytostatic activity against human HepG2 cells after 72 hrs by MTT assay2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID1765574Antibacterial activity against Bacillus subtilis ATCC 23857 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID564973Antimicrobial activity against Mycobacterium bovis BCG by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID575420Antimicrobial activity against anrB-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID717780Antimicrobial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Contribution to investigation of antimicrobial activity of styrylquinolines.
AID1191527Selectivity index, ratio of IC50 for human HepG2 cells to MIC for Staphylococci2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID548472Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID555658Antimicrobial activity against kanamycin-resistant and spr0811-spr0813::aphIII deficient Streptococcus pneumoniae R6 by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID555660Antimicrobial activity against Streptococcus pneumoniae R6 transformed with DNA containing spr0813 C1744T mutant gene selected after vancoresmycin exposure by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID1765576Antibacterial activity against Staphylococcus epidermidis ATCC 12228 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID1191522Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID555652Antimicrobial activity against copY and cyl deficient Streptococcus pneumoniae VarE mutant by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID432804Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL at 37 degC by population analysis method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Role of a sodium-dependent symporter homologue in the thermosensitivity of beta-lactam antibiotic resistance and cell wall composition in Staphylococcus aureus.
AID1191515Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID564985Antimicrobial activity against Mycobacterium bovis BCG KOP55 harboring pPAZ23 carrying p27-p55 operon by resazurine microtiter assay in presence of 1 mg/liter CCCP2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID577707Antibacterial activity against 10'7 CFU/ml telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a at 10 ug after 16 hrs by disk diffusion assay2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
AID717784Antimicrobial activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Contribution to investigation of antimicrobial activity of styrylquinolines.
AID558757Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus deltaIP::vraSH14 harboring vraSH14 S329L mutant gene by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID530544Induction of PtcaA::lacZ gene expression in Staphylococcus aureus SH1000 at 13.4 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID575333Antimicrobial activity against lisK-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID577714Ratio of MIC wild-type Listeria monocytogenes EGD-e Serovar 1/2a to MIC for telA-deficient Listeria monocytogenes EGD-e Serovar 1/2a2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
AID1765579Antibacterial activity against Klebsiella pneumoniae ATCC 700603 incubated for 18 hrs by CLSI based broth dilution method2021Journal of medicinal chemistry, 08-12, Volume: 64, Issue:15
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID558754Antibacterial activity against methicillin-susceptible, tetracycline-resistant and chloramphenicol-resistant Staphylococcus aureus deltaIP-KVR by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID558758Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant and rifampicin-resistant Staphylococcus aureus deltaIP-rifR::vraSH14 by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID530535Induction of PvraSr::lacZ gene expression in Staphylococcus aureus SH1000 at 13.4 ug/ml after 2 hrs by beta-galactosidase reporter gene assay relative to untreated control2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
AID575339Antimicrobial activity against Listeria monocytogenes EGD-e at 10 ug after 16 hrs by disk diffusion assay2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID558752Antibacterial activity against hetero-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus deltaIP by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID1386257Inhibition of mouse His-tagged IDE (42 to 1019 residues) using fluorophore/quencher-tagged RPPGFSAFK(Dnp)-OH peptide as substrate preincubated for 10 mins followed by substrate addition measured over 5 mins by TR-FRET assay2018Journal of medicinal chemistry, 09-27, Volume: 61, Issue:18
Stabilized β-Hairpin Peptide Inhibits Insulin Degrading Enzyme.
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID548253Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID577711Antibacterial activity against 10'5 CFU/ml wild-type Listeria monocytogenes EGD-e Serovar 1/2a after 16 hrs by by two fold serial dilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
AID1191512Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID558759Antibacterial activity against hetero-vancomycin-intermediate Staphylococcus aureus Mu3 by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID555655Antimicrobial activity against Streptococcus pneumoniae VarG transformed with spr0813 C1744T mutant gene by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID1191514Antibacterial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 48 hrs by broth microdilution method2015Bioorganic & medicinal chemistry, Feb-15, Volume: 23, Issue:4
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
AID548471Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID577510Antibacterial activity against 10'7 CFU/ml wild-type Listeria monocytogenes EGD-e Serovar 1/2a at 10 ug after 16 hrs by disk diffusion assay2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
AID717783Antimicrobial activity against methicillin-resistant Staphylococcus aureus H 5996/08 after 24 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Contribution to investigation of antimicrobial activity of styrylquinolines.
AID575423Antimicrobial activity against mprF-deficient Listeria monocytogenes EGD-e assessed as growth inhibition after 16 hrs by broth dilution method relative to wild type2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
AID555656Antimicrobial activity against Streptococcus pneumoniae R6 transformed with DNA containing spr0813 C1744T mutant gene selected after drug exposure by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
AID555653Antimicrobial activity against copY and cyl deficient Streptococcus pneumoniae VarA mutant by agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.55)18.2507
2000's6 (27.27)29.6817
2010's14 (63.64)24.3611
2020's1 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.05 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index5.50 (4.65)
Search Engine Demand Index27.81 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]